BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21821559)

  • 1. Group Health's initiative to avert opioid misuse and overdose among patients with chronic noncancer pain.
    Trescott CE; Beck RM; Seelig MD; Von Korff MR
    Health Aff (Millwood); 2011 Aug; 30(8):1420-4. PubMed ID: 21821559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain.
    Chaudhary S; Compton P
    Subst Abus; 2017; 38(1):95-104. PubMed ID: 27897471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide by means of opioid overdose in patients with chronic pain.
    Madadi P; Persaud N
    Curr Pain Headache Rep; 2014 Nov; 18(11):460. PubMed ID: 25249422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
    Cheatle MD
    Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perils of opioid prescribing during pregnancy.
    Meyer M
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):297-306. PubMed ID: 24845491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.
    Cheatle MD
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):751-4. PubMed ID: 26933873
    [No Abstract]   [Full Text] [Related]  

  • 7. Appropriate care for chronic pain.
    Christopher MJ
    Health Aff (Millwood); 2011 Nov; 30(11):2216; author reply 2216. PubMed ID: 22068414
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Opioid-Use Disorder and Overdose.
    Webster LR
    Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose.
    Garcia AM
    J Law Med Ethics; 2013 Mar; 41 Suppl 1():42-5. PubMed ID: 23590739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of chronic pain management: public health consequences and considered responses.
    Finch JW
    N C Med J; 2013; 74(3):243-5, 247-8. PubMed ID: 23940898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for opioid prescription: the devil is in the details.
    Rosenau AM
    Ann Intern Med; 2013 Jun; 158(11):843-4. PubMed ID: 23567867
    [No Abstract]   [Full Text] [Related]  

  • 15. President's message.
    Morrone WR
    J Addict Dis; 2016; 35(1):67-9. PubMed ID: 26789436
    [No Abstract]   [Full Text] [Related]  

  • 16. Weighing the Risks and Benefits of Chronic Opioid Therapy.
    Lembke A; Humphreys K; Newmark J
    Am Fam Physician; 2016 Jun; 93(12):982-90. PubMed ID: 27304767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight principles for safer opioid prescribing and cautions with benzodiazepines.
    Webster LR; Reisfield GM; Dasgupta N
    Postgrad Med; 2015 Jan; 127(1):27-32. PubMed ID: 25526233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
    Bannwarth B
    Drugs; 2012 Sep; 72(13):1713-23. PubMed ID: 22931520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Naloxone Co-prescription for Patients on Chronic Opioids: a Student-Led Initiative.
    Freise JE; McCarthy EE; Guy M; Steiger S; Sheu L
    J Gen Intern Med; 2018 Jun; 33(6):797-798. PubMed ID: 29556799
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose.
    Von Korff M; Saunders K; Dublin S; Walker RL; Thakral M; Sherman KJ; Ludman EJ; Hansen RN; Parchman M; Shortreed SM
    J Pain; 2019 Jan; 20(1):108-117. PubMed ID: 30189248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.